BeiGene, Ltd. (NASDAQ: BGNE) today announced that REVLIMID® (lenalidomide) has been approved by the China Food and Drug Administration (CFDA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE